Isotopes of molybdenum

(Redirected from Molybdenum-98)

Molybdenum (42Mo) has 39 known isotopes, ranging in atomic mass from 81 to 119, as well as four metastable nuclear isomers. Seven isotopes occur naturally, with atomic masses of 92, 94, 95, 96, 97, 98, and 100. All unstable isotopes of molybdenum decay into isotopes of zirconium, niobium, technetium, and ruthenium.[5]

Isotopes of molybdenum (42Mo)
Main isotopes[1]Decay
abun­dancehalf-life (t1/2)modepro­duct
92Mo14.7%stable
93Mosynth4839 y[2]ε93Nb
94Mo9.19%stable
95Mo15.9%stable
96Mo16.7%stable
97Mo9.58%stable
98Mo24.3%stable
99Mosynth65.94 hβ99mTc
γ
100Mo9.74%7.07×1018 y[1]ββ100Ru
Standard atomic weight Ar°(Mo)

Molybdenum-100, with a half-life of approximately 8.5×1018 y, is the only naturally occurring radioisotope. It undergoes double beta decay into ruthenium-100. Molybdenum-98 is the most common isotope, comprising 24.14% of all molybdenum on Earth. Molybdenum isotopes with mass numbers 111 and up all have half-lives of approximately .15 s.[5]

List of isotopes

Nuclide
[n 1]
ZNIsotopic mass (Da)[6]
[n 2][n 3]
Half-life
[n 4]
Decay
mode

[n 5]
Daughter
isotope

[n 6]
Spin and
parity
[n 7][n 8]
Natural abundance (mole fraction)
Excitation energyNormal proportionRange of variation
81Mo423980.96623(54)#1# msβ+?81Nb5/2+#
β+, p?80Zr
82Mo424081.95666(43)#30# msβ+?82Nb0+
β+, p?81Zr
83Mo424182.95025(43)#23(19) ms
[6(+30-3) ms]
β+83Nb3/2−#
β+, p82Zr
84Mo424283.94185(32)#3.8(9) ms
[3.7(+10-8) s]
β+84Nb0+
85Mo424384.938261(17)3.2(2) sβ+85Nb(1/2−)#
86Mo424485.931174(3)19.6(11) sβ+86Nb0+
87Mo424586.928196(3)14.05(23) sβ+ (85%)87Nb7/2+#
β+, p (15%)86Zr
88Mo424687.921968(4)8.0(2) minβ+88Nb0+
89Mo424788.919468(4)2.11(10) minβ+89Nb(9/2+)
89mMo387.5(2) keV190(15) msIT89Mo(1/2−)
90Mo424889.913931(4)5.56(9) hβ+90Nb0+
90mMo2874.73(15) keV1.12(5) μs8+#
91Mo424990.911745(7)15.49(1) minβ+91Nb9/2+
91mMo653.01(9) keV64.6(6) sIT (50.1%)91Mo1/2−
β+ (49.9%)91Nb
92Mo425091.90680715(17)Observationally Stable[n 9]0+0.14649(106)
92mMo2760.46(16) keV190(3) ns8+
93Mo425192.90680877(19)4839(63) y[2]EC93Nb5/2+
93mMo2424.89(3) keV6.85(7) hIT (99.88%)93Mo21/2+
β+ (.12%)93Nb
94Mo425293.90508359(15)Stable0+0.09187(33)
95Mo[n 10]425394.90583744(13)Stable5/2+0.15873(30)
96Mo425495.90467477(13)Stable0+0.16673(30)
97Mo[n 10]425596.90601690(18)Stable5/2+0.09582(15)
98Mo[n 10]425697.90540361(19)Observationally Stable[n 11]0+0.24292(80)
99Mo[n 10][n 12]425798.90770730(25)2.7489(6) dβ99mTc1/2+
99m1Mo97.785(3) keV15.5(2) μs5/2+
99m2Mo684.5(4) keV0.76(6) μs11/2−
100Mo[n 13][n 10]425899.9074680(3)7.07(14)×1018 a[1]ββ100Ru0+0.09744(65)
101Mo4259100.9103376(3)14.61(3) minβ101Tc1/2+
102Mo4260101.910294(9)11.3(2) minβ102Tc0+
103Mo4261102.913092(10)67.5(15) sβ103Tc(3/2+)
104Mo4262103.913747(10)60(2) sβ104Tc0+
105Mo4263104.916982(10)35.6(16) sβ105Tc(5/2−)
106Mo4264105.918273(10)8.73(12) sβ106Tc0+
107Mo4265106.92212(1)3.5(5) sβ107Tc(7/2−)
107mMo66.3(2) keV470(30) ns(5/2−)
108Mo4266107.924048(10)1.09(2) sβ108Tc0+
109Mo4267108.928438(12)0.53(6) sβ109Tc(7/2−)#
110Mo4268109.930718(26)0.27(1) sβ (>99.9%)110Tc0+
β, n (<.1%)109Tc
111Mo4269110.935652(14)200# ms
[>300 ns]
β111Tc
112Mo4270111.93829(22)#150# ms
[>300 ns]
β112Tc0+
113Mo4271112.94348(32)#100# ms
[>300 ns]
β113Tc
114Mo4272113.94667(32)#80# ms
[>300 ns]
0+
115Mo4273114.95217(43)#60# ms
[>300 ns]
116Mo4274115.95576(54)#32(4) msβ116Tc0+
117Mo4275116.96169(54)#22(5) msβ117Tc3/2+#
118Mo4276117.96525(54)#21(6) msβ118Tc0+
119Mo4277118.97147(32)#12# msβ?119Tc3/2+#
β, n?118Tc
β, 2n?117Tc
This table header & footer:

Molybdenum-99

Molybdenum-99 is produced commercially by intense neutron-bombardment of a highly purified uranium-235 target, followed rapidly by extraction.[7] It is used as a parent radioisotope in technetium-99m generators to produce the even shorter-lived daughter isotope technetium-99m, which is used in approximately 40 million medical procedures annually. A common misunderstanding or misnomer is that 99Mo is used in these diagnostic medical scans, when actually it has no role in the imaging agent or the scan itself. In fact, 99Mo co-eluted with the 99mTc (also known as breakthrough) is considered a contaminant and is minimised to adhere to the appropriate USP (or equivalent) regulations and standards. The IAEA recommends that 99Mo concentrations exceeding more than 0.15 μCi/mCi 99mTc or 0.015% should not be administered for usage in humans.[8] Typically, quantification of 99Mo breakthrough is performed for every elution when using a 99Mo/99mTc generator during QA-QC testing of the final product.

There are alternative routes for generating 99Mo that do not require a fissionable target, such as high or low enriched uranium (i.e., HEU or LEU). Some of these include accelerator-based methods, such as proton bombardment or photoneutron reactions on enriched 100Mo targets. Historically, 99Mo generated by neutron capture on natural isotopic molybdenum or enriched 98Mo targets was used for the development of commercial 99Mo/99mTc generators.[9][10] The neutron-capture process was eventually superseded by fission-based 99Mo that could be generated with much higher specific activities. Implementing feed-stocks of high specific activity 99Mo solutions thus allowed for higher quality production and better separations of 99mTc from 99Mo on small alumina column using chromatography. Employing low-specific activity 99Mo under similar conditions is particularly problematic in that either higher Mo loading capacities or larger columns are required for accommodating equivalent amounts of 99Mo. Chemically speaking, this phenomenon occurs due to other Mo isotopes present aside from 99Mo that compete for surface site interactions on the column substrate. In turn, low-specific activity 99Mo usually requires much larger column sizes and longer separation times, and usually yields 99mTc accompanied by unsatisfactory amounts of the parent radioisotope when using γ-alumina as the column substrate. Ultimately, the inferior end-product 99mTc generated under these conditions makes it essentially incompatible with the commercial supply-chain.

In the last decade, cooperative agreements between the US government and private capital entities have resurrected neutron capture production for commercially distributed 99Mo/99mTc in the United States of America.[11] The return to neutron-capture-based 99Mo has also been accompanied by the implementation of novel separation methods that allow for low-specific activity 99Mo to be utilized.

References